Predicting binding affinities of fosmidomycin analogues as doxp-reductoisomerase inhibitors based on structure-centric approaches

International Journal of Pharma and Bio Sciences

Volumn 3, Issue 4, 2012, Pages 72-91

  Patel, Amiya Kumar ^a  

^a SAMBALPUR UNIVERSITY   (India)

Author keywords

Docking and scoring; Dox reductoisomerase; Drug discovery; Fosmidomycin; Virtual screening

Indexed keywords

3 (N ACETYL N HYDROXYAMINO)PROPYLPHOSPHONIC ACID; BC 183; FOSMIDOMYCIN; ISOMERASE INHIBITOR; KL 562; LD 11; LD 14; LD 15; LD 16; LD 26; LD 27; LD 28; LIHP 83; LIHP 84; LIHP 87; LIHP 88; LTB 59; LTB 65; LTB 66; LTB 95; LTB 97; TK 54; TK 85; UK 153; UK 213; UK 243; UK 513; UK 613; UK 721; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; COMPUTER AIDED DESIGN; COMPUTER PROGRAM; CORRELATION ANALYSIS; CRYSTAL STRUCTURE; DERIVATIZATION; DRUG DESIGN; DRUG STRUCTURE; MATHEMATICAL ANALYSIS; MOLECULAR DOCKING; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MOLECULAR MECHANICS BASED ON GENERALIZED BORN SURFACE AREA; PREDICTION; QUANTUM MECHANICS; QUANTUM MECHANICS POLARIZED LIGAND DOCKING; STRUCTURE ACTIVITY RELATION;

EID: 84873820710     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Malaria Facts. Centers for Disease Control and Prevention (2007).
2. Trape J.F., Pison G., Spiegel A., Enel C. and Rogier C., Combating malaria in Africa. Trends Parasitol, 18: 224-230, (2009).
3. Ralph S. A., Van Dooren G.G., Waller R.F., Crawford M.J., Fraunholz M.J., Foth B.J., Tonkin C.J., Roos D.S. and McFadden G.I., Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast. Nat Reviews Microbiol, 2: 203-216, (2004).
4. Fichera M.E. and Roos D.S., A plastid organelle as a drug target in apicomplexan parasites. Nature, 390: 407-409, (1997).
5. Jomaa H., Wiesner J., Sanderbrand S., Altincicek B., Weidemeyer C., Hintz M., Turbachova I., Eberl M., Zeidler J., Lichtenthaler H.K., Soldati D. and Beck E., Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science, 285: 1573-1576, (1999).
6. Couto A.S., Kimura E.A., Peres V.J., Uhrig M.L. and Katzin A.M., Active isoprenoid pathway in the intra-erythrocytic stages of Plasmodium falciparum: presence of dolichols of 11 and 12 isoprene units.Biochem J, 341: 629-637, (1999).
7. Vial H.J., Isoprenoid biosynthesis and drug targeting in the apicomplexa. Parasitol Today, 16: 140-141, (2000).
8. Lell B., Ruangweerayut R., Wiesner J., Missinou M.A., Schindler A., Baranek T., Hintz M., Hutchinson D., Jomaa H. and Kremsner P.G., Fosmidomycin, a novel chemotherapeutic agent for malaria.Antimicrob Agents Chemothera, 47: 735-738, (2003).
9. Borrmann S., Adegnika A.A., Matsiegui P.B., Issifou S., Schindler A., Mawili-Mboumba D.P., Baranek T., Wiesner J., Jomaa H. and Kremsner P.G., Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children. J Infect Disease, 189: 901-908, (2004).
10. Reichenberg A., Wiesner J., Weidemeyer C., Dreiseidler E., Sanderbrand S., Altincicek B., Beck E., Schlitzer M. and Jomaa H., Diaryl ester prodrugs of FR900098 with improved in vivo antimalarial activity. Bioorg Med Chem Lett, 11: 833-835, (2001).
11. Proteau P.J., Woo Y.H., Williamson R.T. and Phaosiri C., Stereochemistry of the reduction step mediated by recombinant 1-deoxy-D-xylulose 5-phosphate isomeroreductase. Organic Letters, 1: 921-923, (1999).
12. Proteau P.J., 1-Deoxy-D-xylulose 5-phosphate reductoisomerase: an overview.Bioorganic Chemistry, 32: 483-493, (2004).
13. White R.J., Margolis P.S., Trias J. and Yuan Z.Y., Targeting metalloenzymes: a strategy that works. Current Opinion in Pharmacology, 3: 502-507, (2003).
14. Phaosiri C. and Proteau P.J., Substrate analogs for the investigation of deoxyxylulose 5-phosphate reductoisomerase inhibition: synthesis and evaluation. Bioorganic und Medicinal Chemistry Letters, 14: 5309-5312, (2004).
15. Woo Y.H., Fernandes R.P.M. and Proteau P.J., Evaluation of fosmidomycin analogs as inhibitors of the Synechocystis sp. PCC6803 1-deoxy-D-xylulose 5-phosphate reductoisomerase. Bioorganic und Medicinal Chemistry, 14: 2375-2385,(2006).
16. Fernandes R.P.M., Phaosiri C. and Proteau P.J., Mutation in the flexible loop of 1-deoxy-D-xylulose 5-phosphate reductoisomerase broadens substrate utilization. Archives of Biochemistry and Biophysics, 444: 159-164, (2005).
17. Merkle L., De Andres-Gomez A., Dick B., Cox R.J. and Godfrey C.R.A., A fragmentbased approach to understanding inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase. Chembiochem, 6: 1866-1874, (2005).
18. Singh N., Cheve G., Avery M.A. and McCurdy C.R., Comparative protein modeling of 1-deoxy-D-xylulose-5-phosphate reductoisomerase enzyme from Plasmodium falciparum: A potential target for antimalarial drug discovery. Journal of Chemical Information and Modeling, 46:1360-1370, (2006).
19. Steinbacher S., Kaiser J., Eisenreich W., Huber R., Bacher A. and Rohdich F., Structural basis of fosmidomycin action revealed by the complex with 2-C-methyl-Derythritol 4-phosphate synthase (IspC).Implications for the catalytic mechanism and anti-malaria drug development. J Biol.Chem., 278: 18401-18407, (2003).
20. Friesner R.A., Banks J.L., Murphy R.B., Halgren T.A., Klicic J.J., Mainz D.T., Repasky M.P., Knoll E.H., Shelley M., Perry J.K., Shaw D.E., Francis P. and Shenkin P.S., Glide: a new approach for rapid,accurate docking and scoring. 1. Method and assessment of docking accuracy.Journal of medicinal chemistry, 47: 1739-1749, (2004).
21. Eldridge M.D., Murray C.W., Auton T.R., Paolini G.V. and Mee R.P., Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. Journal of computer-aided molecular design, 11: 425-445, (1997).
22. Cho A.E., Guallar V., Berne B.J. and Friesner R., Importance of accurate charges in molecular docking: Quantum mechanical/molecular mechanical (QM/MM) approach. J. Comput. Chem, 26: 915-931,(2005).
23. Silber K., Ligand-und Rezeptor-basierte Suchstrategien zum Auffinden neuer Proteininhibitoren. Halle Wittenberg (2001).
24. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., Olson A.J., Automated Docking using a Lamarckian genetic algorithm and empirical binding free energy function. J. Computational Chemistry, 19: 1639-1662, (1998).